Evidence map›Paper›PMID 30474140›Full record

ArticleJournal of clinical laboratory analysis2019

Combined testing for herpes simplex virus and Mycobacterium tuberculosis DNA in cerebrospinal fluid of patients with aseptic meningitis in Burkina Faso, West Africa.

Sylvie Zida, Pratt Kolia-Diafouka, Dramane Kania, Albert Sotto, Vincent Foulongne, Karine Bolloré, Soumeya Ouangraoua, Nicolas Méda, Séverine Carrère-Kremer, Philippe Van de Perre and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Global Landscape of Encephalitis: Key Priorities to Reduce Future Disease Burden.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sylvie ZidaUMR 1058, INSERM/EFS/Université de Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0003-1727-2291
Pratt Kolia-DiafoukaUMR 1058, INSERM/EFS/Université de Montpellier, Montpellier, France.
Dramane KaniaCentre MURAZ, Bobo Dioulasso, Burkina Faso.
Albert SottoERI 26, INSERM, Nîmes, France.
Vincent FoulongneUMR 1058, INSERM/EFS/Université de Montpellier, Montpellier, France.
Karine BolloréUMR 1058, INSERM/EFS/Université de Montpellier, Montpellier, France.
Soumeya OuangraouaCentre MURAZ, Bobo Dioulasso, Burkina Faso.
Nicolas MédaMinistère de la santé, Ouagadougou, Burkina Faso.
Séverine Carrère-KremerUMR 1058, INSERM/EFS/Université de Montpellier, Montpellier, France.
Philippe Van de PerreUMR 1058, INSERM/EFS/Université de Montpellier, Montpellier, France.
Edouard TuaillonUMR 1058, INSERM/EFS/Université de Montpellier, Montpellier, France.
Inserm · FRCentre Muraz · BFMinistère De La Santé · BF

Funding

Mediterranean Infection Foundation
6 · The paper itself

Abstract

backgroundLittle is known about the involvement of herpes simplex virus (HSV) or Mycobacterium tuberculosis (MTB) as potentially curable causes of central nervous system (CNS) infections in sub-Saharan Africa.

objectiveIn this study, we developed a PCR assay dedicated to simultaneous testing of HSV1/HSV2 and MTB in Burkina Faso, a country where HSV is neglected as a cause of CNS infection and where TB prevalence is high.

methodsA consensus HSV1/HSV2 set of primers and probe were designed and combined to primers and probe targeting the IS6110 repetitive insertion sequence of MTB. Analytical performances of the assay were evaluated on reference materials. Cerebrospinal fluid (CSF) collected from subjects with aseptic meningitis was tested for HSV1/HSV2 and MTB DNA.

resultsThe UL29 gene was chosen as a highly conserved region targeted by the HSV1/HSV2 nucleic acid test. The lower limits of detection were estimated to be 2.45 copies/µL for HSV1, 1.72 copies/µL for HSV2, and 2.54 IS6110 copies per µL for MTB. The PCR was used in 202 CSF collected from subjects suspected of aseptic meningitis. Five samples (2.46%) tested positive, including two children positive for HSV1 (0.99%) and three adults tested positive for MTB (1.47%).

conclusionUsing an in-house real-time PCR assay, we showed that both HSV and MTB are etiologic pathogens contributing to aseptic meningitis in Burkina Faso. This molecular test may have clinical utility for early diagnosis for those treatable CNS infections.

Indexed as

AdultBurkina FasoChildDNA, BacterialDNA, ViralHerpes SimplexHerpesvirus 1, HumanHerpesvirus 2, HumanHumansLimit of DetectionMeningitis, AsepticMolecular TypingMycobacterium tuberculosisTuberculosis, MeningealDNA, BacterialDNA, Viralcerebrospinal fluidherpes simplex virusmeningitisMycobacterium tuberculosisPCR

Identifiers

PMID30474140
PMCPMC6818613
OpenAlexW2902983537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.